c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
BioLineRx sells APHEXDA royalty rights for $5.6 million
Investing.com | Nov 18, 2026 7:04 AM EST
Read original article